$10.41
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Country

IE

CEO

Mr. Patrick Lockwood-Taylor

IPO date

1991

Employees

8,100

ISIN

IE00BGH1M568

Key stats

Open

$10.41

Volume

2.77M

Market cap

$1.46B

Prev. close

$10.41

Impl / hst vl

-

Open interest

$0.00

$10.38

Day’s Range

$10.82

$9.23

52W Range

$15.27

Valuation

38
Valuation score
Overvalued
P/E
-
P/S
0.35
P/B
0.59
Current ratio
2.72
Debt / Equity
1.31
ROE
-50.65%
Gross margin
33.58%
Income growth
-71.89%
FCF growth
-185.73

Jun

16

Dividends

The last payment date was Jun 16, 2026

Div. per Share

$0.29

Div. Yield

2.76%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$15.81
The top 5 analysts forecasts that 12-month price may increase by 51.87%, with a low of $14.14 and a high of $17.85
$14.14
Low
$15.81
Avg
$17.85
High
Current price

Earnings

Q1 ‘26 revenue
$969.20M
Q1 ‘26 net income
-$398.60M
Revenue
Net income
Previous EPS
$0.79
Estimate EPS
$0.32
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply